Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity

Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity

US Patent 6903101 · Granted Jun 7, 2005

Estimated economic value: $590,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline forms of 4-ethoxy-n-(2-methoxyethyl)-n-methyl-3-(5-methyl-4-oxo-7-pr2025
Nucleoside phosphoramidate prodrugs2024
Phenoxy-pyridyl-pyrimidine compounds and methods of use2024
Anti-CD38 antibodies and formulations2023
Nucleoside phosphoramidate prodrugs2023
3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]tria2021
Intermediates useful in the synthesis of compounds as modulators of protein kina2021
Pyridazine derivatives as RORc modulators2021
Selective PI3K delta inhibitors2021
Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related d2021
Piperidine derivatives as inhibitors of ubiquitin specific protease 72020
Aryl ureas with angiogenisis inhibiting activity2020